https://www.eurekalert.org/pub_releases/2020-09/esoc-lzl092220.php
News Release 22-Sep-2020
European Society of Clinical Microbiology and Infectious Diseases
New research presented at this week's ESCMID Conference on Coronavirus Disease (ECCVID, held online from 23-25 September) shows that having a lower level of zinc in the blood is associated with a poorer outcome in patients with COVID-19. The study is by Dr Roberto Güerri-Fernández, Hospital Del Mar, Barcelona, Spain, and colleagues.
Increased intracellular zinc concentrations efficiently impair replication/reproduction of a number of viruses.
•••••
After adjusting by age, sex, severity and receiving hydroxychloroquine,
statistical analysis showed each unit increase of plasma zinc at
admission to hospital was associated with a 7% reduced risk of
in-hospital mortality. Having a plasma zinc level lower than 50mcg/dl at
admission was associated with a 2.3 times increased risk of in-hospital
death compared with those patients with a plasma zinc level of 50mcg/dl
or higher.
•••••
No comments:
Post a Comment